| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.009 | 4.513 | 4.020 | - | - | - | - | - | - |
| Total Income - EUR | - | 9.009 | 4.513 | 4.020 | - | - | - | - | - | - |
| Total Expenses - EUR | - | 2.893 | 487 | 461 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | - | 6.116 | 4.025 | 3.559 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | - | 5.845 | 3.890 | 3.438 | - | - | - | - | - | - |
| Employees | - | 1 | 0 | 0 | - | - | - | - | - | - |
Check the financial reports for the company - Lotus Diagnostica-Chimie Clinică Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 38 | 38 | 37 | - | - | - | - | - | - |
| Current Assets | - | 59.795 | 58.497 | 65.202 | - | - | - | - | - | - |
| Inventories | - | 1.452 | 1.030 | 641 | - | - | - | - | - | - |
| Receivables | - | 46.408 | 45.858 | 53.257 | - | - | - | - | - | - |
| Cash | - | 11.935 | 11.609 | 11.304 | - | - | - | - | - | - |
| Shareholders Funds | - | 51.820 | 54.833 | 57.265 | - | - | - | - | - | - |
| Social Capital | - | 45 | 44 | 43 | - | - | - | - | - | - |
| Debts | - | 8.013 | 3.701 | 7.974 | - | - | - | - | - | - |
| Income in Advance | - | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Lotus Diagnostica-Chimie Clinică Srl